Published 3 October 2022 Pulmonary hypertension, high blood pressure in the lung, is a devastating condition where no curative treatment is available. Christian Westöö, PhD student in Karin Tran Lundmark's research team, has used synchrotron-based micro-CT as a tool for increased understanding of disease distribution in 3D space, in human tissue from patients with pulmonary arterial hypertension.

https://www.wcmm.lu.se/article/3d-visualization-vascular-lesions-and-role-versican-pulmonary-arterial-hypertension - 2025-04-19

Published 3 October 2022 Within 5 years after his recruitment for the Wallenberg Centre of Molecular Medicine at Lund University, which brought Principal Investigator Filipe Pereira in 2017 to Sweden, he has been appointed full Professorship in Molecular Medicine, Regeneration, Transplantation and Repair in the Hematopoietic System. The academic path of Filipe Pereira has taken him from Portugal t

https://www.wcmm.lu.se/article/filipe-pereira-appointed-full-professor-lund-university - 2025-04-19

Published 3 October 2022 Shortly after the great news that Paul Bourgine, associate senior lecturer in Molecular Skeletal Biology at the Wallenberg Centre for Molecular Medicine, Lund University, was awarded the ERC Proof of Concept grant, two new press-releases have been published in Dagens Medicin and News Cision acknowledging the great work and novel funding of a new confocal microscope for his

https://www.wcmm.lu.se/article/press-releases-about-bourgine-lab - 2025-04-19

Published 4 October 2022 Are you a fan of popular science communication? Are you interested in presenting your work in an open and casual setting outside the scientific community? Well, now you can!  The communications team proudly presents the WCMM ScienceBrew: a new series of popular science talks featuring selected popular science talks by PhD students and postdocs at at Lund university.  The W

https://www.wcmm.lu.se/article/wcmm-sciencebrew - 2025-04-19

Published 3 November 2022 This year Prince Daniel's grant for particularly promising young researchers was awarded WCMM researcher Andreas Edsfeldt for his research on atherosclerosis in type 2 diabetes. The Swedish Heart-Lung Foundation wishes to foster the next generation of young researchers. One way in which it does this is by awarding grants to particularly promising young researchers. Andrea

https://www.wcmm.lu.se/article/prince-daniels-research-grant-andreas-edsfeldt - 2025-04-19

Published 3 November 2022 For those of you that maybe did not know, WCMM Lund has a Scientific Advisory Board (SAB) composed of four internationally recognized experts. Two of them know the WCMM Centre quite well by now and the other two are just newly recruited. The role of the WCMM SAB is to provide strategic guidance and direction the WCMM Centre regarding scientific aspects, strategic directio

https://www.wcmm.lu.se/article/get-know-scientific-advisory-board - 2025-04-19

Published 3 November 2022 Chimezie Harrison Umeano is a new graduate student in regenerative immunology at Nicholas Leigh’s lab. He has a background in biochemistry and biomedicine and has previously been engaged as a laboratory technician at the Karolinska Institute. Chimezie is interested in how highly regenerative species like salamanders modulate their immune system to promote regeneration. As

https://www.wcmm.lu.se/article/welcome-chimezie-harrison-umeano - 2025-04-19

Published 3 November 2022 Dopamine-producing neurons that researchers from Lund University have grown in the laboratory from human embryonic stem cells (Photo: Agneta Kirkeby) An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from

https://www.wcmm.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2025-04-19

Published 3 November 2022 The Pereira group is seeking for 1 post-doctoral candidate for a collaborative project with the company Asgard therapeutics. The Pereira group has pioneered cell fate reprogramming approaches in immunology with induced dendritic cells (Rosa et al, Science Immunology 2018; Rosa et al, Science Immunology 2022) and has shown recently that the same combination of factors can

https://www.wcmm.lu.se/article/open-position - 2025-04-19

Published 3 November 2022 Patient neuroblastoma cells (yellow) in a humanized ossicle. Picture by Dimitra Zacharaki, postdoctoral researcher The Bourgine lab has published a new article in Science Translational Medicine reporting the fast and standardized generation of human mini-bones/humanized ossicles, and assess to what extent they can reflect the human bone marrow microenvironment. Human ossi

https://www.wcmm.lu.se/article/new-publication-science-translational-medicine - 2025-04-19

By Anders [dot] Martensson [at] med [dot] lu [dot] se (Anders Mårtensson) - published 26 October 2018 New webpage has been created and a change of technology Due to updates in technology a brand new webpage for WCMM has now been created. We hope you find this to your liking.

https://www.wcmm.lu.se/article/new-webpage - 2025-04-19

Published 8 December 2022 WCMM researcher Andreas Edsfeldt has been awarded the SSMF consolatory grant, a five-year grant that gives prominent researchers the opportunity to strengthen their position as independent researchers, for his research on the role of cell death in diabetes-associated cardiovascular disease. Diabetes mellitus type 2 (T2D) is rapidly increasing worldwide, and people with T2

https://www.wcmm.lu.se/article/role-cell-death-diabetes-associated-cardiovascular-disease - 2025-04-19

Published 8 December 2022 Sandra Lindstedt has received 19.5 MSEK, the grant for clinical studies within therapy research from the Swedish Research Counsil, for her project entitled “Cytokine filtration at lung transplantation”. This grant aims to enable a constellation of researchers within regions and academia to work towards a common research goal. The purpose is to provide support for clinical

https://www.wcmm.lu.se/article/195-msek-clinical-wcmm-researcher - 2025-04-19

Publicerad 16 augusti 2018 En av TEDDY´s grundare och huvudperson, Jeffrey Krischer från USA, blir hedersdoktor vid Lunds universitet. Så här presenterade Lunds universitet Jeffrey Krischer inför promoveringen i Lunds domkyrka den 25 maj 2018:Professor Jeffrey P Krischer, är verksam vid University of South Florida, USA och är en av världens främsta experter på mekanismerna bakom autoimmuna sjukdom

https://www.teddy.lu.se/artikel/teddy-forskare-hedersdoktor - 2025-04-19

Publicerad 21 augusti 2018 Under Almedalsveckan diskuterades om det ska införas en allmän screening vid fyraårs ålder för att upptäcka de barn som kommer att drabbas av autoimmun (typ 1) diabetes. Frågan är aktuell eftersom vi idag kan förutse ett insjuknande i autoimmun diabetes flera år i förväg.På seminariet deltog några av våra forskare och koordinatorer i TEDDY och andra studier i CAP (Center

https://www.teddy.lu.se/artikel/allman-screening-autoimmun-typ-1-diabetes - 2025-04-19

Publicerad 3 oktober 2018 Hur ser kunskapsläget för autoimmun diabetes ut idag?Vad vet vi om ärftlighet, omgivningens betydelse, sjukdomens tre utvecklingssteg och möjligheterna med en tidig upptäckt?På Diabetesportalen.se kan ni läsa en sammanfattning av en artikel som beskriver detta. Artikeln är skriven av Åke Lernmark och Simon Regnéll och publicerad i Diabetologia.Diabetesportalen.se (nytt fö

https://www.teddy.lu.se/artikel/autoimmun-typ-1-diabetes-vad-vet-vi - 2025-04-19

Publicerad 3 oktober 2018 TEDDY-studien finansieras av NIH (amerikanska hälsovårdsministeriet) och har nu fått drygt 40 miljoner kronor för att fortsätta studien i ytterligare fem år. Tack vare TEDDY-studien har kunskapen om vad som händer före en person insjuknar i autoimmun (typ 1) diabetes eller i celiaki ökat.  Läs om TEDDY-studiens fortsatta finansiering och reslutat på Diabetesportalen.se (n

https://www.teddy.lu.se/artikel/teddy-studien-far-40-miljoner-att-fortsatta - 2025-04-19

Publicerad 5 november 2018 Nu har det gått 14 år sedan TEDDY-studien startade och det finns en hel del resultat att presentera. I ett brev till alla TEDDY-familjer har vi gjort en sammanfattning av resultaten de hjälpt oss att få fram. Läs brevet "Vad har TEDDY kommit fram till".   Om du vill veta mer om våra resultat så hittar du dem under fliken ”Resultat från TEDDY”. Där finns våra publikatione

https://www.teddy.lu.se/artikel/vad-har-teddy-kommit-fram-till - 2025-04-19

Publicerad 20 december 2018 Tack vare att TEDDY-föräldrarna skickat in avföringsprover från sina barn varje månad, har den hittills största kliniska studien av tarmfloran hos spädbarn kunnat genomföras.I  två artiklar i Nature presenteras resultaten:Hur utvecklas bakterierna i tarmfloran under TEDDY-barnens första levnadsår?Skiljer sig tarmfloran mellan barn som utvecklar autoimmun (typ 1) diabete

https://www.teddy.lu.se/artikel/intressanta-resultat-fran-teddy-studien-har-publicerats-i-den-vetenskapliga-tidskriften-nature - 2025-04-19

Publicerad 8 mars 2019 Senaste numret av Vårdförbundets tidning Vårdfokus har tema diabetes. I en artikel om TEDDY-studien berättar deltagaren Viggo om hur det är att vara med i TEDDY och professor Åke Lernmark intervjuas om de senaste inom diabetesforskningen. Läs artikeln om TEDDY-studien på vårdfokus.se (nytt fönster).

https://www.teddy.lu.se/artikel/teddy-i-tidningen-vardfokus - 2025-04-19